Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 271


Activation of innate immunity by 14-3-3 ε, a new potential alarmin in osteoarthritis.

Millerand M, Sudre L, Nefla M, Pène F, Rousseau C, Pons A, Ravat A, Andre-Leroux G, Akira S, Satoh T, Berenbaum F, Jacques C.

Osteoarthritis Cartilage. 2020 Mar 12. pii: S1063-4584(20)30916-X. doi: 10.1016/j.joca.2020.03.002. [Epub ahead of print]


Alternative and complementary therapies in osteoarthritis and cartilage repair.

Fuggle NR, Cooper C, Oreffo ROC, Price AJ, Kaux JF, Maheu E, Cutolo M, Honvo G, Conaghan PG, Berenbaum F, Branco J, Brandi ML, Cortet B, Veronese N, Kurth AA, Matijevic R, Roth R, Pelletier JP, Martel-Pelletier J, Vlaskovska M, Thomas T, Lems WF, Al-Daghri N, Bruyère O, Rizzoli R, Kanis JA, Reginster JY.

Aging Clin Exp Res. 2020 Mar 13. doi: 10.1007/s40520-020-01515-1. [Epub ahead of print] Review.


Osteoarthritis and inflammation: a serious disease with overlapping phenotypic patterns.

Berenbaum F, Walker C.

Postgrad Med. 2020 Feb 26:1-8. doi: 10.1080/00325481.2020.1730669. [Epub ahead of print]


Osteoarthritis year in review 2019: epidemiology and therapy.

Kloppenburg M, Berenbaum F.

Osteoarthritis Cartilage. 2020 Mar;28(3):242-248. doi: 10.1016/j.joca.2020.01.002. Epub 2020 Jan 13. Review.


Association between Vitamin D deficiency and disease activity, disability and radiographic progression in early rheumatoid arthritis. The ESPOIR cohort.

Mouterde G, Gamon E, Rincheval N, Lukas C, Seror R, Berenbaum F, Dupuy AM, Daien C, Daurès JP, Combe B.

J Rheumatol. 2019 Dec 15. pii: jrheum.190795. doi: 10.3899/jrheum.190795. [Epub ahead of print]


Development of a core capability framework for qualified health professionals to optimise care for people with osteoarthritis: an OARSI initiative.

Hinman RS, Allen KD, Bennell KL, Berenbaum F, Betteridge N, Briggs AM, Campbell PK, Dahlberg LE, Dziedzic KS, Eyles JP, Hunter DJ, Skou ST, Woolf A, Yu SP, van der Esch M.

Osteoarthritis Cartilage. 2020 Feb;28(2):154-166. doi: 10.1016/j.joca.2019.12.001. Epub 2019 Dec 12.


Is hip osteoarthritis preventable?

Courties A, Berenbaum F.

Joint Bone Spine. 2019 Dec 4. pii: S1297-319X(19)30176-9. doi: 10.1016/j.jbspin.2019.11.010. [Epub ahead of print] No abstract available.


Contribution of adipocyte precursors in the phenotypic specificity of intra-articular adipose tissues in knee osteoarthritis patients.

Eymard F, Pigenet A, Rose C, Bories A, Flouzat-Lachaniette CH, Berenbaum F, Chevalier X, Houard X, Nourissat G.

Arthritis Res Ther. 2019 Nov 27;21(1):252. doi: 10.1186/s13075-019-2058-9.


Mobile Health Apps for Self-Management of Rheumatic and Musculoskeletal Diseases: Systematic Literature Review.

Najm A, Gossec L, Weill C, Benoist D, Berenbaum F, Nikiphorou E.

JMIR Mhealth Uhealth. 2019 Nov 26;7(11):e14730. doi: 10.2196/14730. Review.


Cartilage-gut-microbiome axis: a new paradigm for novel therapeutic opportunities in osteoarthritis.

Berthelot JM, Sellam J, Maugars Y, Berenbaum F.

RMD Open. 2019 Sep 20;5(2):e001037. doi: 10.1136/rmdopen-2019-001037. eCollection 2019. Review.


[Arthrosis: 10 key messages].

Berenbaum F, Sellam J.

Rev Prat. 2019 May;69(5):522-524. French. No abstract available.


Danger signals and inflammaging in osteoarthritis.

Millerand M, Berenbaum F, Jacques C.

Clin Exp Rheumatol. 2019 Sep-Oct;37 Suppl 120(5):48-56. Epub 2019 Oct 15. Review.


EULAR points to consider for the development, evaluation and implementation of mobile health applications aiding self-management in people living with rheumatic and musculoskeletal diseases.

Najm A, Nikiphorou E, Kostine M, Richez C, Pauling JD, Finckh A, Ritschl V, Prior Y, Balážová P, Stones S, Szekanecz Z, Iagnocco A, Ramiro S, Sivera F, Dougados M, Carmona L, Burmester G, Wiek D, Gossec L, Berenbaum F.

RMD Open. 2019 Sep 13;5(2):e001014. doi: 10.1136/rmdopen-2019-001014. eCollection 2019.


The opioid epidemic: helping rheumatologists prevent a crisis.

Trouvin AP, Berenbaum F, Perrot S.

RMD Open. 2019 Aug 6;5(2):e001029. doi: 10.1136/rmdopen-2019-001029. eCollection 2019. Review.


Gut microbiota and osteoarthritis management: An expert consensus of the European society for clinical and economic aspects of osteoporosis, osteoarthritis and musculoskeletal diseases (ESCEO).

Biver E, Berenbaum F, Valdes AM, Araujo de Carvalho I, Bindels LB, Brandi ML, Calder PC, Castronovo V, Cavalier E, Cherubini A, Cooper C, Dennison E, Franceschi C, Fuggle N, Laslop A, Miossec P, Thomas T, Tuzun S, Veronese N, Vlaskovska M, Reginster JY, Rizzoli R.

Ageing Res Rev. 2019 Nov;55:100946. doi: 10.1016/j.arr.2019.100946. Epub 2019 Aug 19. Review.


Current status of use of big data and artificial intelligence in RMDs: a systematic literature review informing EULAR recommendations.

Kedra J, Radstake T, Pandit A, Baraliakos X, Berenbaum F, Finckh A, Fautrel B, Stamm TA, Gomez-Cabrero D, Pristipino C, Choquet R, Servy H, Stones S, Burmester G, Gossec L.

RMD Open. 2019 Jul 18;5(2):e001004. doi: 10.1136/rmdopen-2019-001004. eCollection 2019.


Comparative effect of tumour necrosis factor inhibitors versus other biological agents on cardiovascular risk-associated biomarkers in patients with rheumatoid arthritis.

Virone A, Bastard JP, Fellahi S, Capeau J, Rouanet S, Sibilia J, Ravaud P, Berenbaum F, Gottenberg JE, Sellam J.

RMD Open. 2019 Jul 21;5(2):e000897. doi: 10.1136/rmdopen-2019-000897. eCollection 2019.


Calprotectin alone is not sufficient to predict response to methotrexate in early ACR/EULAR 2010 rheumatoid arthritis: Analysis of the ESPOIR cohort.

Bernardy C, Lejeune S, Courtier A, Wendling D, Berenbaum F, Nguyen MVC, Gaudin P, Paclet MH, Baillet A.

Joint Bone Spine. 2020 Jan;87(1):99-100. doi: 10.1016/j.jbspin.2019.07.001. Epub 2019 Jul 17. No abstract available.


EULAR points to consider for the use of big data in rheumatic and musculoskeletal diseases.

Gossec L, Kedra J, Servy H, Pandit A, Stones S, Berenbaum F, Finckh A, Baraliakos X, Stamm TA, Gomez-Cabrero D, Pristipino C, Choquet R, Burmester GR, Radstake TRDJ.

Ann Rheum Dis. 2020 Jan;79(1):69-76. doi: 10.1136/annrheumdis-2019-215694. Epub 2019 Jun 22.


Overview of osteo-articular involvement in systemic sclerosis: Specific risk factors, clinico-sonographic evaluation, and comparison with healthy women from the French OFELY cohort.

Thietart S, Louati K, Gatfosse M, Sornay-Rendu E, Gaigneux E, Lemeunier L, Delmaire P, Riviere S, Mahevas T, Sellam J, Berenbaum F, Fain O, Roland C, Mekinian A.

Best Pract Res Clin Rheumatol. 2018 Aug;32(4):591-604. doi: 10.1016/j.berh.2019.01.008. Epub 2019 Feb 20. Review.


Association between osteoarthritis and increased risk of dementia: A systemic review and meta-analysis.

Weber A, Mak SH, Berenbaum F, Sellam J, Zheng YP, Han Y, Wen C.

Medicine (Baltimore). 2019 Mar;98(10):e14355. doi: 10.1097/MD.0000000000014355.


A Phase II Trial of Lutikizumab, an Anti-Interleukin-1α/β Dual Variable Domain Immunoglobulin, in Knee Osteoarthritis Patients With Synovitis.

Fleischmann RM, Bliddal H, Blanco FJ, Schnitzer TJ, Peterfy C, Chen S, Wang L, Feng S, Conaghan PG, Berenbaum F, Pelletier JP, Martel-Pelletier J, Vaeterlein O, Kaeley GS, Liu W, Kosloski MP, Levy G, Zhang L, Medema JK, Levesque MC.

Arthritis Rheumatol. 2019 Jul;71(7):1056-1069. doi: 10.1002/art.40840. Epub 2019 Jun 7.


Report from the Hand Osteoarthritis Working Group at OMERACT 2018: Update on Core Instrument Set Development.

Wittoek R, Kroon FPB, Kundakci B, Abhishek A, Haugen IK, Berenbaum F, Conaghan PG, Ishimori ML, Smeets W, van der Heijde D, Kloppenburg M.

J Rheumatol. 2019 Sep;46(9):1183-1187. doi: 10.3899/jrheum.181003. Epub 2019 Jan 15.


Impairment of glyoxalase-1, an advanced glycation end-product detoxifying enzyme, induced by inflammation in age-related osteoarthritis.

Trellu S, Courties A, Jaisson S, Gorisse L, Gillery P, Kerdine-Römer S, Vaamonde-Garcia C, Houard X, Ekhirch FP, Sautet A, Friguet B, Jacques C, Berenbaum F, Sellam J.

Arthritis Res Ther. 2019 Jan 11;21(1):18. doi: 10.1186/s13075-018-1801-y.


The Phenotypic Approach to Osteoarthritis: A Look at Metabolic Syndrome-Associated Osteoarthritis.

Courties A, Berenbaum F, Sellam J.

Joint Bone Spine. 2019 Nov;86(6):725-730. doi: 10.1016/j.jbspin.2018.12.005. Epub 2018 Dec 22.


Phase IIa, placebo-controlled, randomised study of lutikizumab, an anti-interleukin-1α and anti-interleukin-1β dual variable domain immunoglobulin, in patients with erosive hand osteoarthritis.

Kloppenburg M, Peterfy C, Haugen IK, Kroon F, Chen S, Wang L, Liu W, Levy G, Fleischmann RM, Berenbaum F, van der Heijde D, Bansal P, Wittoek R, Feng S, Fang Y, Saltarelli M, Medema JK, Levesque MC.

Ann Rheum Dis. 2019 Mar;78(3):413-420. doi: 10.1136/annrheumdis-2018-213336. Epub 2018 Dec 14.


TGFβi is involved in the chondrogenic differentiation of mesenchymal stem cells and is dysregulated in osteoarthritis.

Ruiz M, Maumus M, Fonteneau G, Pers YM, Ferreira R, Dagneaux L, Delfour C, Houard X, Berenbaum F, Rannou F, Jorgensen C, Noël D.

Osteoarthritis Cartilage. 2019 Mar;27(3):493-503. doi: 10.1016/j.joca.2018.11.005. Epub 2018 Nov 28.


Immunological and clinical effects of low-dose interleukin-2 across 11 autoimmune diseases in a single, open clinical trial.

Rosenzwajg M, Lorenzon R, Cacoub P, Pham HP, Pitoiset F, El Soufi K, RIbet C, Bernard C, Aractingi S, Banneville B, Beaugerie L, Berenbaum F, Champey J, Chazouilleres O, Corpechot C, Fautrel B, Mekinian A, Regnier E, Saadoun D, Salem JE, Sellam J, Seksik P, Daguenel-Nguyen A, Doppler V, Mariau J, Vicaut E, Klatzmann D.

Ann Rheum Dis. 2019 Feb;78(2):209-217. doi: 10.1136/annrheumdis-2018-214229. Epub 2018 Nov 24.


Targeting nerve growth factor to relieve pain from osteoarthritis: What can we expect?

Berenbaum F.

Joint Bone Spine. 2019 Mar;86(2):127-128. doi: 10.1016/j.jbspin.2018.09.009. Epub 2018 Sep 26. No abstract available.


Modern-day environmental factors in the pathogenesis of osteoarthritis.

Berenbaum F, Wallace IJ, Lieberman DE, Felson DT.

Nat Rev Rheumatol. 2018 Nov;14(11):674-681. doi: 10.1038/s41584-018-0073-x. Review.


Clinical and multi-omics cross-phenotyping of patients with autoimmune and autoinflammatory diseases: the observational TRANSIMMUNOM protocol.

Lorenzon R, Mariotti-Ferrandiz E, Aheng C, Ribet C, Toumi F, Pitoiset F, Chaara W, Derian N, Johanet C, Drakos I, Harris S, Amselem S, Berenbaum F, Benveniste O, Bodaghi B, Cacoub P, Grateau G, Amouyal C, Hartemann A, Saadoun D, Sellam J, Seksik P, Sokol H, Salem JE, Vicaut E, Six A, Rosenzwajg M, Bernard C, Klatzmann D.

BMJ Open. 2018 Aug 30;8(8):e021037. doi: 10.1136/bmjopen-2017-021037.


Deep phenotyping of osteoarthritis: a step forward.

Berenbaum F.

Ann Rheum Dis. 2019 Jan;78(1):3-5. doi: 10.1136/annrheumdis-2018-213864. Epub 2018 Aug 28. No abstract available.


Correction to: Development and application of a questionnaire to assess patient beliefs in rheumatoid arthritis and axial spondyloarthritis.

Gossec L, Berenbaum F, Chauvin P, Hudry C, Cukierman G, de Chalus T, Dreuillet C, Saulot V, Tong S, Russo-Marie F, Joubert JM, Saraux A.

Clin Rheumatol. 2018 Oct;37(10):2659. doi: 10.1007/s10067-018-4241-9.


Development and application of a questionnaire to assess patient beliefs in rheumatoid arthritis and axial spondyloarthritis.

Gossec L, Berenbaum F, Chauvin P, Hudry C, Cukierman G, de Chalus T, Dreuillet C, Saulot V, Tong S, Russo-Marie F, Joubert JM, Saraux A.

Clin Rheumatol. 2018 Oct;37(10):2649-2657. doi: 10.1007/s10067-018-4172-5. Epub 2018 Jun 12. Erratum in: Clin Rheumatol. 2018 Aug 24;:.


Increase In Il-31 Serum Levels Is Associated With Reduced Structural Damage In Early Axial Spondyloarthritis.

Rosine N, Etcheto A, Hendel-Chavez H, Seror R, Briot K, Molto A, Chanson P, Taoufik Y, Wendling D, Lories R, Berenbaum F, van den Berg R, Claudepierre P, Feydy A, Dougados M, Roux C, Miceli-Richard C.

Sci Rep. 2018 May 16;8(1):7731. doi: 10.1038/s41598-018-25722-z.


Effects of a Single Intra-Articular Injection of a Microsphere Formulation of Triamcinolone Acetonide on Knee Osteoarthritis Pain: A Double-Blinded, Randomized, Placebo-Controlled, Multinational Study.

Conaghan PG, Hunter DJ, Cohen SB, Kraus VB, Berenbaum F, Lieberman JR, Jones DG, Spitzer AI, Jevsevar DS, Katz NP, Burgess DJ, Lufkin J, Johnson JR, Bodick N; FX006-2014-008 Participating Investigators.

J Bone Joint Surg Am. 2018 Apr 18;100(8):666-677. doi: 10.2106/JBJS.17.00154.


Diabetes at the time of rheumatoid arthritis diagnosis is an independent predictor of pejorative outcomes: Data from the early arthritis ESPOIR cohort.

Daïen CI, Sellam J, Rincheval N, Fautrel B, Saraux A, Morel J, Berenbaum F, Daurès JP, Combe B.

Joint Bone Spine. 2018 Dec;85(6):773-775. doi: 10.1016/j.jbspin.2018.02.004. Epub 2018 Feb 23. No abstract available.


Association between osteoarthritis and dyslipidaemia: a systematic literature review and meta-analysis.

Baudart P, Louati K, Marcelli C, Berenbaum F, Sellam J.

RMD Open. 2017 Aug 29;3(2):e000442. doi: 10.1136/rmdopen-2017-000442. eCollection 2017.


Challenges and Advances in Targeting Remission in Axial Spondyloarthritis.

Baraliakos X, Berenbaum F, Favalli EG, Olivieri I, Ostendorf B, Poddubnyy D, DE Vlam K.

J Rheumatol. 2018 Feb;45(2):153-157. doi: 10.3899/jrheum.170222. No abstract available.


e-Health, social media, and rheumatology: Can they get along?

Berenbaum F.

Joint Bone Spine. 2018 May;85(3):265-266. doi: 10.1016/j.jbspin.2017.12.007. Epub 2017 Dec 13. No abstract available.


'Twitterland': a brave new world?

Nikiphorou E, Studenic P, Alunno A, Canavan M, Jani M, Berenbaum F.

Ann Rheum Dis. 2018 Aug;77(8):1245-1246. doi: 10.1136/annrheumdis-2017-212273. Epub 2017 Dec 4. No abstract available.


Development and psychometric validation of a patient-reported outcome measure to assess fears in rheumatoid arthritis and axial spondyloarthritis: the Fear Assessment in Inflammatory Rheumatic diseases (FAIR) questionnaire.

Gossec L, Chauvin P, Saraux A, Hudry C, Cukierman G, de Chalus T, Dreuillet C, Saulot V, Tong S, Russo-Marie F, Joubert JM, Berenbaum F.

Ann Rheum Dis. 2018 Feb;77(2):258-263. doi: 10.1136/annrheumdis-2017-212000. Epub 2017 Nov 4.


Brief Report: A Phase IIb Trial of a Novel Extended-Release Microsphere Formulation of Triamcinolone Acetonide for Intraarticular Injection in Knee Osteoarthritis.

Conaghan PG, Cohen SB, Berenbaum F, Lufkin J, Johnson JR, Bodick N.

Arthritis Rheumatol. 2018 Feb;70(2):204-211. doi: 10.1002/art.40364. Epub 2017 Dec 20.


Autoimmune manifestations associated with lymphoma: characteristics and outcome in a multicenter retrospective cohort study.

Jachiet V, Mekinian A, Carrat F, Grignano E, Retbi A, Boffa JJ, Ronco P, Rondeau E, Sellam J, Berenbaum F, Chazouillères O, Capron J, Alamowitch S, Chasset F, Frances C, Coppo P, Fain O; French Network of systemic and immune disorders associated with hemopathies and cancer (MINHEMON).

Leuk Lymphoma. 2018 Jun;59(6):1399-1405. doi: 10.1080/10428194.2017.1379075. Epub 2017 Oct 3.


Evolution of pain at 3 months by oral resveratrol in knee osteoarthritis (ARTHROL): protocol for a multicentre randomised double-blind placebo-controlled trial.

Nguyen C, Boutron I, Baron G, Coudeyre E, Berenbaum F, Poiraudeau S, Rannou F.

BMJ Open. 2017 Sep 29;7(9):e017652. doi: 10.1136/bmjopen-2017-017652.


Role of the autonomic nervous system in osteoarthritis.

Courties A, Sellam J, Berenbaum F.

Best Pract Res Clin Rheumatol. 2017 Oct;31(5):661-675. doi: 10.1016/j.berh.2018.04.001. Review.


Osteoarthritis: Research in motion.

Berenbaum F, Kloppenburg M.

Best Pract Res Clin Rheumatol. 2017 Oct;31(5):611-612. doi: 10.1016/j.berh.2018.07.001. Epub 2018 Sep 7. No abstract available.


Cardiometabolic risk factors in primary centred and rotator cuff-related shoulder osteoarthritis: a comparative study.

Juge PA, Berard L, Kotti S, Doursounian L, Sautet A, Simon T, Berenbaum F, Nourissat G, Sellam J.

RMD Open. 2017 Jun 29;3(1):e000429. doi: 10.1136/rmdopen-2016-000429. eCollection 2017.


Poor efficacy of TNF inhibitors in non-radiographic axial spondyloarthritis in the absence of objective signs: A bicentric retrospective study.

Vidal C, Lukas C, Combe B, Berenbaum F, Pers YM, Jorgensen C, Sellam J, Morel J.

Joint Bone Spine. 2018 Jul;85(4):461-468. doi: 10.1016/j.jbspin.2017.08.005. Epub 2017 Sep 14.


The nuclear factor-erythroid 2-related factor/heme oxygenase-1 axis is critical for the inflammatory features of type 2 diabetes-associated osteoarthritis.

Vaamonde-Garcia C, Courties A, Pigenet A, Laiguillon MC, Sautet A, Houard X, Kerdine-Römer S, Meijide R, Berenbaum F, Sellam J.

J Biol Chem. 2017 Sep 1;292(35):14505-14515. doi: 10.1074/jbc.M117.802157. Epub 2017 Jul 6.

Supplemental Content

Loading ...
Support Center